128 related articles for article (PubMed ID: 16906044)
1. The transgenic expression of human CD39 on murine islets inhibits clotting of human blood.
Dwyer KM; Mysore TB; Crikis S; Robson SC; Nandurkar H; Cowan PJ; D'Apice AJ
Transplantation; 2006 Aug; 82(3):428-32. PubMed ID: 16906044
[TBL] [Abstract][Full Text] [Related]
2. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
3. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells.
De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685
[TBL] [Abstract][Full Text] [Related]
6. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
7. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
[TBL] [Abstract][Full Text] [Related]
8. Ischemic Cerebroprotection Conferred by Myeloid Lineage-Restricted or Global CD39 Transgene Expression.
Baek AE; Sutton NR; Petrovic-Djergovic D; Liao H; Ray JJ; Park J; Kanthi Y; Pinsky DJ
Circulation; 2017 Jun; 135(24):2389-2402. PubMed ID: 28377485
[TBL] [Abstract][Full Text] [Related]
9. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
[TBL] [Abstract][Full Text] [Related]
11. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
Dwyer KM; Robson SC; Nandurkar HH; Campbell DJ; Gock H; Murray-Segal LJ; Fisicaro N; Mysore TB; Kaczmarek E; Cowan PJ; d'Apice AJ
J Clin Invest; 2004 May; 113(10):1440-6. PubMed ID: 15146241
[TBL] [Abstract][Full Text] [Related]
12. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.
Barat C; Martin G; Beaudoin AR; Sévigny J; Tremblay MJ
J Mol Biol; 2007 Aug; 371(1):269-82. PubMed ID: 17560607
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
[TBL] [Abstract][Full Text] [Related]
14. Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis.
Zimmermann H
Nat Med; 1999 Sep; 5(9):987-8. PubMed ID: 10470068
[No Abstract] [Full Text] [Related]
15. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
Pulte D; Olson KE; Broekman MJ; Islam N; Ballard HS; Furman RR; Olson AE; Marcus AJ
J Transl Med; 2007 May; 5():23. PubMed ID: 17480228
[TBL] [Abstract][Full Text] [Related]
16. Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis.
Yadav V; Chi L; Zhao R; Tourdot BE; Yalavarthi S; Jacobs BN; Banka A; Liao H; Koonse S; Anyanwu AC; Visovatti SH; Holinstat MA; Kahlenberg JM; Knight JS; Pinsky DJ; Kanthi Y
J Clin Invest; 2019 Apr; 129(7):2872-2877. PubMed ID: 30990798
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.
Koziak K; Bojakowska M; Robson SC; Bojakowski K; Soin J; Csizmadia E; Religa P; Gaciong Z; Kaczmarek E
J Thromb Haemost; 2008 Jul; 6(7):1191-7. PubMed ID: 18485080
[TBL] [Abstract][Full Text] [Related]
18. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
[TBL] [Abstract][Full Text] [Related]
20. CD39 modulates IL-1 release from activated endothelial cells.
Imai M; Goepfert C; Kaczmarek E; Robson SC
Biochem Biophys Res Commun; 2000 Apr; 270(1):272-8. PubMed ID: 10733939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]